Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theseus Pharmaceuticals, Inc. - Common Stock (NQ:THRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theseus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX
From Kahn Swick & Foti, LLC
Via Business Wire
Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and... 
Via Benzinga
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! 
Via InvestorPlace
Analyst Expectations for Theseus Pharmaceuticals's Future
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Dow Jumps Over 500 Points; Home Depot Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 500 points on Tuesday. The Dow traded up 1.60% to 34,885.58 while the NASDAQ rose 2.50% to 14,111.61. The S&P... 
Via Benzinga
Topics Stocks
Crude Oil Moves Higher; Beauty Health Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 500 points on Tuesday. The Dow traded up 1.42% to 34,833.89 while the NASDAQ rose 2.34% to 14,089.95. The S&P 500... 
Via Benzinga
Topics Stocks
Nasdaq Surges 2%; US Inflation Rate Slows In October
U.S. stocks traded higher this morning, with the Dow Jones gaining around 400 points on Tuesday. Following the market opening Tuesday, the Dow traded up 1.16% to 34,736.95 while the NASDAQ rose 2.03%... 
Via Benzinga
Topics Economy Stocks
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst
Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market. 
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
Via Benzinga
$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P... 
Via Benzinga
Setback For Theseus Pharmaceuticals: Analysts Cut Price Targets But Remain Bullish On Stock
Theseus Pharmaceuticals Inc (NASDAQ: THRX) shares nose-dived after the company announced discontinuing enrollment in the ongoing phase 1/2 study and terminating the development of THE-630 in patients... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also... 
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,555.27 while the NASDAQ rose 0.36% to... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
 
Via Benzinga
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Plug Power (PLUG) stock is getting a boost on Friday after Northland Securities analysts upgraded the hydrogen fuel cell company's shares. 
Via InvestorPlace
Dose-Limiting Toxicities: Theseus Pharma Terminates THE-630 Study For Gastrointestinal Cancer
Theseus Pharmaceuticals Inc (NASDAQ: THRX) will discontinue enrollment in the ongoing phase 1/2 study and terminate the development of THE-630 in patients with  
Via Benzinga
Why Is Leslies (LESL) Stock Down 36% Today?
Leslies (LESL) stock is falling on Friday after the company released its preliminary earnings report for the third quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Is Theseus Pharmaceuticals (THRX) Stock Down 68% Today?
Theseus Pharmaceuticals (THRX) stock is falling hard on Friday after the company announced poor results from a Phase 1/2 clinical trial. 
Via InvestorPlace
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.